Literature DB >> 7647412

Insulin autoimmune syndrome after the third therapy with methimazole.

M Hakamata1, M Itoh, Y Sudo, N Miyata.   

Abstract

In 1986, a 26-year-old female had been diagnosed as having Graves' disease and had been treated with methimazole for four months. After the treatment with propylthiouracil for another four months, she had been treated with methimazole once again. She was in complete remission for two years. She again experienced symptoms of hyperthyroidism, and treatment with methimazole was started again. On the thirteenth day after treatment, she experienced hypoglycemic attacks with skin eruption. The plasma glucose was 57 mg/dl, 125I-Insulin binding 69%, free IRI 196 microU/ml. The patient had the HLA-DRB1*0406.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7647412     DOI: 10.2169/internalmedicine.34.410

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  2 in total

Review 1.  Methimazole-induced insulin autoimmune syndrome.

Authors:  Nidhi Jain; Malvi Savani; Manyoo Agarwal; Dipen Kadaria
Journal:  Ther Adv Endocrinol Metab       Date:  2016-07-19       Impact factor: 3.565

Review 2.  Case Report: Recurrent Autoimmune Hypoglycemia Induced by Non-Hypoglycemic Medications.

Authors:  Qiuping Zhu; Hanxin Zhao; Wei Qiu; Fang Wu; Chungen Qian; Yonghong Yang; Ye Kang; Fenping Zheng; Jiaqiang Zhou
Journal:  Front Immunol       Date:  2022-07-22       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.